October Newsletter features Zephyr Sleep CEO interview, FDA Updates

Ever wonder why we’re called StarFish?  Check out Scott’s video for the key “points” in our October Newsletter.


  • Paul Cataford, Zephyr Sleep Technologies CEO, talks about the North American roll-out of MATRx™ – the company’s Medical Device for determining whether oral appliance therapy will treat Obstructive Sleep Apnea
  • FDA impacted by US Budget shutdown
  • StarFish Medical’s Director of Quality/Regulatory, Vesna Janic comments on recent FDA Guidances
  • Vincent Crabtree provides insight on:  FDA issues final guidance on mobile medical apps, New rapid blood test can differentiate between bacterial and viral infections, and Phonebloks: The smartphone for the rest of your life.

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.